Computer Methods in Biomechanics and Biomedical Engineering
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q3
WOS
Q3
Impact factor
1.7
SJR
0.421
CiteScore
4.1
Categories
Bioengineering
Biomedical Engineering
Computer Science Applications
Human-Computer Interaction
Medicine (miscellaneous)
Areas
Chemical Engineering
Computer Science
Engineering
Medicine
Years of issue
1997-2025
journal names
Computer Methods in Biomechanics and Biomedical Engineering
COMPUT METHOD BIOMEC
Top-3 citing journals

Computer Methods in Biomechanics and Biomedical Engineering
(2168 citations)

Journal of Biomechanics
(2011 citations)

Journal of Biomechanical Engineering
(933 citations)
Top-3 organizations

Aix-Marseille University
(80 publications)

Katholieke Universiteit Leuven
(56 publications)

Sorbonne University
(50 publications)

Beihang University
(30 publications)

Sichuan University
(18 publications)

Sorbonne Paris Nord University
(18 publications)
Most cited in 5 years
Found
Publications found: 463
Q3

Isolation of Nutmeg Essential Oil (Myristica fragrans houtt) From Aceh Indonesia and Their Antioxidant and Antibacterial Activities
Khairan K., Faradilla M., Ginting B.
This study aims to isolate the nutmeg essential oil (Myristica fragrans Houtt) from Aceh Indonesia and evaluate their biological activity. The antioxidant activity of the nutmeg essential oils (Myristica fragrans Houtt) was determined by DPPH (1,1-difenil-2-pikrihidrazil) assay. The DPPH assay showed that arillus essential oil (AMFH) has the highest antioxidant activity with the IC50 values was 216,695 ppm. The chemical composition of the AMFH was perfomed by Gas Chromatography-Mass Spectroscopy (GC-MS), and the results showed that AMFH contains Terpinen-4-ol (T-4-ol), α-Terpineol (α-T), Safrole (Saf) and Myristicin (Myr) with the percentage area of 11.20%; 1.83%; 5.10%; and 27.80% respectively. The AMFH was isolated by column chromatography and four fractions were obtained, namely AMFH1; AMFH2; AMFH3; and AMFH4 fractions. The DPPH assay showed that the AMFH3 fraction showed excellent antioxidant activity with the IC50 values of 59.329 ppm. The AMFH3 fraction was than reisolated by using by column chromatography to obtain four subfractions namely AMFH3A; AMFH3B; AMFH3C; and AMFH3D. The DPPH assay showed that the subfraction of AMFH3A has the highest antioxidant activity with the IC50 values of 98.993 ppm. The antibacterial activity of AMFH3A subfractions was evaluated by Kirby Bauer-Disc diffusion method, and the results showed that AMFH3A subfraction showed slightly higher activity against Staphylococcus epidermidis and Staphylococcus aureus with the diameter inhibition of 14.28 mm and 12.26 mm respectively. The chemical composition of the AMFH3A subfraction was performed by GC-MS, and the results showed that AMFH3A subfraction contains Terpinen-4-ol (T-4-ol), α-Terpineol (α-T), Safrole (Saf) and Myristicin (Myr) with the percentage area of 14.37%; 2.16%; 7.36%; and 54.77% respectively.
Q3

Zinc Sulfate and α-tocopherol Supplementation Enhance Reproductive Performance in Male Albino Rats (Rattus norvegicus) With Lead Acetate Toxicity
Prastiya R.A., Sardjito T., Agustono B., Fikri F., Saputro A.L., Wurlina W., Dewi B.L., Pratiwi S.M., Nugroho A.P., Moses I.B.
Metal toxicity from lead affects reproductive organ function by activating reactive oxygen species processes. This study aims to see how α-tocopherol and zinc sulfate (ZnSO4) affect gonads, liver, follicle-stimulating hormone, luteinizing hormone, spermatogenesis (the amount of spermatogonia, spermatocytes, and spermatids), and Leydig cells in male albino rats (Rattus norvegicus) exposed to lead acetate Pb(CH3COO)2. The samples used were 25 male Wistar rats aged 4 months, separated into five groups. For 30 days, all treatment groups were exposed to Pb(CH3COO)2 at a level of 50-mg/kg body weight (BW). The T1 group was given a dosage of 100-mg/kg BW of α-tocopherol. The ZnSO4 was given to the T2 group at a dose of 0.54-mg/kg BW. Meanwhile, the T3 group was given a mixture of ZnSO4 at 0.54-mg/kg BW and α-tocopherol at 100-mg/kg BW orally. ELISA test was carried out to determine the level of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in a blood plasma sample of 100 μl / 1 mg. Histopathological observations made on the liver included counting damaged cells and seminiferous tubules that included counting the amount of spermatogonia, spermatocytes, spermatids, Sertoli cells, and Leydig cells. Using SPSS 20 software, the collected data were analyzed using analysis of variance, followed by Duncan’s test with a 95% simultaneous confidence level. The highest average levels of FSH and LH in the T3 group were 3.6162 mIU/mL and 14.9658 mIU/mL. The finding showed that Pb(CH3COO)2 caused disruptions in the spermatogenesis and Leydig cell processes. Exogenous antioxidants in combination with ZnSO4 and α-tocopherol had significant effect on enhancing reproductive performance in animals exposed to Pb(CH3COO)2.
Q3

Clinical Decision Support Systems to Identify Drug-Related Problems in Diabetes Mellitus Patients: A Systematic Review
Larasati N., Satibi S., Kristina S.A., Lazuardi L.
Clinical Decision Support Systems (CDSSs) has been developed for utilization to provide rational therapy to Diabetes Mellitus (DM) patients including preventing Drug-related Problems (DRPs) such as the effect of drug treatment being not optimal, untreated indications and symptoms, unnecessary therapy, and adverse drug reactions. This study aims to summarize the available evidence on the intervention of CDSSs, key outputs, and impact of the user in DM patients. This study was a systematic review using PubMed, Scopus database, and by manually searching the bibliographies of articles that have been found. We included studies reporting on evaluated CDSSs that had been implemented in medication prescription, reducing medication errors, adverse drug events, drug-allergy checking, drug dosing support, and so on. A total of 8 studies were selected among 855 studies. CDSSs are used in hospitals and primary care settings to identify potential drug interactions, correct therapy regimens, monitor therapy, blood glucose documentation, ensure patients receive medication according to the guideline, provide nutritional advice, and schedule physical activity. The usage of CDSSs improves blood glucose levels, detects possible drug interactions, reduces face-to-face consultations, improves documentation, assists in identifying dose, and promotes prescribing in line with the guideline. The use of CDSSs can help to reduce the risk of errors in management therapy.
Q3

Comparative Cellular and In Vivo Anti-cancer studies of Doxorubicin Liposomes Prepared with Different Types of Phospholipids
Miatmoko A., Cahyani D.M., Kawano K., Hattori Y.
The selection of lipid components of membrane bilayer determines the rigidity of liposomes affecting drug efficacy, especially for cancer drug delivery. The present study evaluated liposomes with different rigidity for delivering doxorubicin (DOX). In this work, liposomes composed of rigid lipid, hydrogenated soybean phosphatidylcholine (HSPC), were totally or partially substituted with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). The liposomes are composed of phosphatidylcholine (HSPC, POPC), with and without combination with DOPE, cholesterol, and DSPE-mPEG2000 with a molar ratio of 57: 38: 5, respectively. Liposomes were prepared using a thin layer hydration method. Then, in vitro cytotoxicity and in vivo antitumor activity of these liposomes were evaluated. Substitution of HSPC with POPC resulted in similar cytotoxicities profiles similar to the DOX solution on C26 colon cancer cells and LLC cells. The DOPE addition to DOX liposomes reduced the antitumor activity. In conclusion, the lipid substitution of HSPC with POPC or DOPE reduced liposome rigidity; however, it lowered the in vivo antitumor activity.
Q3

Simultaneous Quantification of Ramipril and Ramiprilat in Drug Formulations: A Clinical LC-MS/MS Study
Omari K., Abu-Awwad A., Arafat B., Macovei G., Boltez T., Abdel Baki Z., Mallah E., Arafat T.
Ramipril is a drug controlling hypertension. Two drugs were studied in 36 healthy adults. The drugs are the test (Atb®) and the reference (Tritace®). This concept is crucial in the pharmaceutical industry during the development process. The maximum concentration (Cmax) of Ramipril and its metabolite (Ramiprilat) were determined throughout drug administration in healthy subjects. All analysis was performed using LC-MS/MS. The method was validated over a range of 0.200 – 25.000 ng/mL in which linearity (R2) was 0.9983, accuracy was 99.9%, precision (CV) was less than 20%, and the Lower Limit of Quantitation was 0.200 ng/mL. Stability and other parameters were discussed. The time needed to reach this concentration (Tmax) and the time-drug concentration area under the curve (AUC) were most agreed upon. The two drugs were proven to be interchangeable. Both have similar pharmacokinetics and bioequivalence profiles. Consequently, the drugs are bioequivalent and considered alternatives to one another pharmaceutically. For example, 90% confidence intervals (C.I.) for the in-tra-individual ratios (test/reference) for pharmacokinetic parameters were Cmax, and AUC0-t for total exposure C.I. Log – transformed Values were 80-125 %.
Q3

Phytochemical, Nutraceutical and Pharmacological Aspects of the Philippine native Acalypha angatensis Blanco, Fl. Filip.
Hipol R.L., Wayas H., Bacuyag F.M., Daquigan M., Hipol R., Cabanlong J.
The genus Acalypha has valuable species that have significant pharmaceutical applications. This study investigated the phytochemical composition and thin layer chromatography (TLC) profile, as well as the antioxidant and antibacterial activities of the ethanolic extract of Acalypha pulogensis Sagun & G.A. Levin, an endemic species in the Philippines. Qualitative phytochemical screening revealed the presence of tannins, phenolics, flavonoids, saponins, steroids, and triterpenoids. Nutrient analysis showed that potassium and calcium content were at 1499 mg/100 g and 1380 mg/100 g, respectively. The determination of the total phenolic content (TPC) showed that this species has an average of 282.24 ± 3.56 mg GAE/g and a total flavonoid content (TFC) of 36.24 ± 3.77 mg QE/g of dried extract. These values were found to be higher than those of other Acalypha species. Antioxidant activity was measured using DPPH antioxidant assay, and the extract showed a concentration-dependent radical scavenging effect with an IC50 of 34.02 µg/mL. Antibacterial activity was evaluated using various concentrations against drug-resistant Gram-positive and Gram-negative bacteria using a resazurin-based assay. The ethanolic extract exhibited substantial antibacterial activity against Enterococcus faecium (NCTC 12204) and MRSA (ATCC 33592), with a minimum inhibitory concentration (MIC) of 4 mg/mL. Higher concentrations (>20 mg/mL) were needed for inhibition of the Gram-negative strains (Klebsiella pneumoniae and Enterobacter cloacae). These results suggest that A. pulogensis has good antioxidant and antibacterial activities that support its use in traditional medicine.
Q3

Physico-Chemical and Structural Characterization of Mixed Natural Polymer Hydrogels Under Simulated Gastrointestinal Fluid
Hastuti A.A., Zai K., Risdanareni P., Karolina R., Mustafa I.
The gastrointestinal track has a varied pH, from an acidic pH in the stomach to a slightly basic pH in the intestine. The pH difference creates problems for the delivery of drugs and nutrients, as the active compounds may not survive the changing pH. Incorporating active ingredients into hydrogels can protect the compounds from degradation. Natural polymer hydrogel is preferable because of its safety and compatibility. However, a suitable formula should be optimized to facilitate suitable delivery in the gastrointestinal track. In this study, we produced hydrogels with 10 different formulas of mixed natural polymers: CMC (C), alginate (A), chitosan (X), and/or guar gum (G). The resulting hydrogels were characterized using swelling performance tests at pH 2 and 6.8, Fourier-transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). Hydrogels with the formula of C50A25X25, C25A50X25, C25A50G25, C25A25G50, C25A50X12.5G12.5, and C25A25X25G25 are not digested at pH 2, but those hydrogels are digested at pH 6.8. The FTIR spectra of the hydrogels show functional groups of O–H, C=O, C–O, and C–H. Meanwhile, the SEM results show cracking phenomena on the surface of the hydrogels C50A25X12.5G12.5, C25A50X12.5G12.5, and C25A25X25G25. This study offers a general guide for the development of a natural polymer hydrogel as a suitable nutrient vehicle in the gastrointestinal track. Formulation of each type of nutrient should be optimized for optimum delivery to the designated part of the gastrointestinal track.
Q3

Gut Microbiota Dynamics and Phenotypic Changes Induced by Tetracycline in Drosophila melanogaster
Saadjad Z.P., Sartini S., Chairatunnisa R., Latada N.P., Mudjahid M., Nainu F.
Gut microbiota plays a crucial role in both physiological and pathological processes in humans and animals. Antibiotics, designed to combat bacterial infections, can induce alterations in the composition and abundance of the gut microbiota over prolonged exposure. This study addresses the limited understanding of the connections between gut microbiota and phenotypic profiles of metazoan species. We investigated the impact of early-life exposure to tetracycline in wild-type D. melanogaster, which were fed a standard diet, comparing them to a control group not exposed to tetracycline. The primary objective was to examine the consequences of early-life tetracycline exposure on gut microbiota and its implications for phenotypic profiles, including survival, locomotor activity, and reproduction in adult flies. Results revealed a significant reduction in lactic acid bacteria in adult flies exposed to tetracycline. However, tetracycline exhibited no interference with fly development, allowing them to maintain a normal lifespan. In adult flies, tetracycline significantly decreased the lifespan on day 35 at a concentration of 1000 µg/mL and reduced locomotion on day 27 at concentrations of 10 µg/mL and 1000 µg/mL. Remarkably, tetracycline did not impact the reproductive capabilities of the flies. This study demonstrates that while tetracycline led to a decline in lactic acid bacteria, locomotion, and lifespan in adult flies, it did not disrupt their development or reproductive processes.
Q3

Analytical Method Validation and Simultaneous Determination of Ketotifen Fumarate and Cyproheptadine Hydrochloride in Divided Powder by RP-HPLC Method
Dewi M.S., Riswanto F.D., Yuliani S.H.
Ketotifen fumarate and cyproheptadine HCl are the most popular prescription for children at “X” hospital in Yogyakarta. The interest for studying this divided powder was related to the stability test towards human health. Hence, it was important to developed a validated analytical method to quantify content of active drug from sample. In this study, a reversed phase HPLC (RP-HPLC) method was validated and applied for determining content of ketotifen fumarate and cyproheptadine hydrochloride in divided powder. The developed RP-HPLC method was met the requirement of selectivity and sensitivity. Calibration curve formulas of ketotifen fumarate and cyproheptadine hydrochloride were y = 27714x-79111 (r=0.9945) and y = 26324x+72581 (r=0.9935) in the range of 10.9-54.5 and 10.6-53.0 µg/mL, respectively. Accuracy and intermediate precision were assessed on both standard solution and samples spiked with standard solution of ketotifen fumarate and cyproheptadine hydrochloride. It was found that both standard solution and the spiked samples solution were met the requirement of recovery of 80-110% and RSD of less than 7.3% for intraday and interday analysis. Content of ketotifen fumarate and cyproheptadine hydrochloride in sample (n=7) were 16.574±0.098 and 30.640±0.035 µg/mL, respectively. It can be concluded that the RP-HPLC method was successfully validated and applied in the determination of ketotifen fumarate and cyproheptadine hydrochloride in divided powder.
Q3

Formulation of Lotion with Ethanol Extract of Curcuma manga Val. as UV B Sunscreen and Activity Test using UV-Vis Spectrophotometry
Kusumorini N., Zulkarnain A.K.
Temu mango (Curcuma manga Val) is a rhizome plant native to Indonesia that contains curcuminoid and flavonoid antioxidant compounds. These compounds are thought to have activity as UV light protectors, especially UV B. This study uses a qualitative test of the compound content in temu mango followed by formulation and activity testing of water in oil (w/o) sunscreen lotion of temu mango in vitro. Optimization of w/o lotion formulation uses Design Expert® (DE) software version 9.0.4.1 with the Simplex Lattice Design method. The DE software obtained 13 runs of w/o lotion formula and continued with physical properties evaluation to determine the optimum formula. The optimum formula of lotion w/o predicted by DE software was tested for physical stability for four weeks, SPF test, percent pigmentation, and percent erythema using UV-Vis spectrophotometry. The results of the study show that temu mango extract was found to provide an SPF value at a concentration of 0.3 mg/mL with an SPF value of 16.62. The results of the optimum formula of lotion w/o were 7%glycerin, 7% cera alba, 5% cetyl alcohol with a value of stickiness of 0.70 ± 0.03 seconds, spreadability of 13.20 ± 0.83 cm2, and viscosity of 95.19 ± 3.06 dPa.s. Referring to the storage results, the optimum formula of w/o lotion from temu mango extract was stable during one month of storage. The w/o lotion in the optimum formula produced an SPF value of 15.06 ± 0.39, percent erythema of 10.95%, and percent pigmentation of 10.41%.
Q3

Beta-Blocker in Heart Rate Control and Cardio Protection: The Role of ADRB1 Variants and HCN4 Regulation – A Systematic Review
Niruri R., Ikawati Z., Nugroho A.E., Arifianto H.
Elevated heart rate is linked to adverse cardiovascular outcomes. Sinoatrial (SA) nodes, hyperpolarization-activated cyclic nucleotide-gated-4 (HCN4) channels, and beta1-adrenergic receptor (ADRB1) are responsible for generating the heart rate. Beta-blockers have a cardioprotective effect on heart failure, including controlling heart rate. However, the responses to beta-blockers can vary among individuals. ADRB1 genetic variability may be contributed to the differential beta-blocker effect in heart failure. HCN4 also performs a crucial function in the pacemaker cells of the heart. Exploring the effect of beta-blockers in pacemaker cells is expanding the view of their role and their therapeutic response in heart failure. The objectives of this study were to identify ADRB1 genetic variants affecting heart rate response in heart failure subjects with beta-blocker treatment and to explore the effect of beta-blockers on HCN4 channels and SA nodes. A systematic review was performed using three databases. Eight of 668 manuscripts were selected. The systematic review found that ADRB1 genetic variants (A145G (Ser49Gly) and C1165G (Arg389Gly)) can affect heart rate response in beta-blocker-treated heart failure. The study also found that the percentage of patients with the Ser49Ser-Gly389X haplotype achieved a heart rate target was higher than other haplotypes. Individuals with the Arg389Arg genotype necessitated a markedly increased amount of beta-blocker dose to reach the identical heart rate target compared to those with the Gly389X gene variation. In addition, the review found that carvedilol, a beta-blocker derivative, demonstrated beneficial effects in inhibiting HCN-gated channels. Bisoprolol and carvedilol improved channel regulation in the SA Node by reversing the downregulation of HCN4 and sodium channels. In general, this systematic review provides important insights into beta-blockers in treating heart failure, specifically concerning the genetic variability of ADRB1 and the beta-blockers effect on the SA node and HCN4 channels.
Q3

The Role of Growth Differentiation Factor-15 in the Diagnosis of Patients with Chronic Angina Undergoing Coronary Angiography
Butti A., Abbas W.A., Hasan A.Y.
Coronary artery disease (CAD) is considered the most prevalent leading cause of myocardial ischemia and mortality worldwide and can lead to angina pectoris and myocardial infarction (MI). Growth Differentiation Factor-15 (GDF-15) is usually measured together with other biomarkers to predict all-cause mortality. During stressful conditions associated with tissue injury and inflammation like myocardial ischemia, it is released into circulation and detected at high concentration in foam cells of the atherosclerotic plaque. Its circulating levels are associated with chronic diseases rather than acute diseases mainly cardiovascular diseases (CVDs) like CAD and chronic heart failure (CHF). The aim of the current study was to detect the role of GDF-15 as a new biomarker for the diagnosis of stable angina patients with normal left ventricular ejection fraction who were presented as having stable chest pain, so that to avoid endangering them to the invasive coronary angiography. Fasting venous blood samples were taken from 90 participants who were presented as having chest pain. They were all subjected to echocardiography, electrocardiography and coronary angiography. The left ventricular ejection fraction was calculated using the biplane M mode method. GDF-15 serum level was measured by using Human GDF-15 Sandwich ELISA Kit following the manufacturer’s instructions.The current study detected a high significant difference in the serum levels of GDF-15 and serum creatinine between the patients and the control group (P≤0.01). On the other hand, there were significant differences in the serum levels of triglycerides and VLDL-C between both study groups (P≤0.05). ROC curve analysis showed that GDF-15 had AUC= 1.00, the best cut off= 254.16 with sensitivity and specificity of 100%. So, it can be concluded that GDF-15 could be used as a biomarker for the diagnosis of stable angina patients with obstructive atherosclerotic plaque and normal LV ejection fraction.
Q3

Validation of An HPLC Method for the Determination of Some Β-Lactams Antibiotics Using A Green Analytical Technique
Nguyen T.D., Phuong A.T., Truong Quoc K.
Green analytical chemistry (GAC) primary goal is to develop environmental and health-friendly analytical methods by reduction or replacement of hazardous substances from analytical procedures. In this research, the application of GAC to quantify five β-lactams antibiotics (cefuroxime sodium, cefaclor, ertapenem sodium, ampicillin sodium and sulbactam sodium) by high-performance liquid chromatography (HPLC) using photodiode arrays (PDA) detector was developed. To achieve this, ethanol was used as a green replacement for methanol and acetonitrile, common solvents in chromatographic procedures. Several chromatographic conditions were investigated to accomplish the optimal conditions. The method validation followed the ICH Q2 (R1) guideline, and the developed method was successfully applied for quantifying some pharmaceutical products.
Q3

PyPLIF HIPPOS-aided Construction and Retrospective Validation of Structure-Based Virtual Screening Protocol Targeting VEGFR2
Supanji S., Perdamaian A.B., Marsifah T., Istighfari Jenie R., Ikawati M., Kartikawati Paramita D., Perdana Istyastono E.
Recently, the discovery of small molecules as inhibitors for vascular endothelial growth factor receptor 2 (VEGFR2) is of timely interest, especially in the area of ocular neovascular diseases. On the other hand, PyPLIF HIPPOS in combination with machine learning techniques has been reported to increase the prediction quality of structure-based virtual screening (SBVS) protocols. The original version of PyPLIF has served in the development of an SBVS protocol that successfully identified novel chalcone derivatives and short peptides as potent inhibitors for acetylcholinesterase. In this short communication, construction and retrospective validation of an SBVS protocol employing PyPLIF HIPPOS targeting VEGFR2 are presented to make it publicly available. The retrospective validation employed 409 active compounds and 24,950 decoys from the enhanced version of the directory of useful decoys. All compounds were docked independently 3 times using AutoDock Vina followed by the identification of the protein-ligand interaction fingerprints (PLIF) employing PyPLIF HIPPOS. The derived ensemble PLIF descriptors were then used in the decision tree construction using a machine-learning technique called recursive partitioning and regression trees. The best decision was then incorporated in the SBVS protocol. The F-measure and enrichment factor values of the SBVS protocol were 0.387 and 76.879, respectively. Hence, the SBVS protocol is readily available to screen small molecules or short peptides.
Q3

Optimizing the Formula of Polymeric-Based Aripiprazole Nanosuspension Using Response Surface Methodology for Intranasal Drug Delivery
Aisiah N.F., Surini S.
This study aimed to optimize the formula of aripiprazole nanosuspension for intranasal drug delivery. Response Surface Methodology (RSM) was employed to determine the influence of independent variables, including drug concentration, polymer concentration, and the ratio of polymer combination, on the nanosuspension characteristics. The parameters under investigation were particle size (d mean), polydispersity index, and drug content. Fifteen formulas were prepared using the high-shear homogenization–ultrasonication method, and the Design Expert software was applied for optimum formula determination. The result showed significant effects of the independent variables on the nanosuspension characteristics, with particle sizes ranging from 143.6 – 334.6 nm, PDI values of 0.302 – 0.649, and drug content was 98.7 – 102.1 %. The predicted optimum formula had a drug concentration of 28 mg/mL in the organic solvent, polymer concentration of 1.5% (w/v), and HPMC to PVP ratio of 1.4 with desirability of 0.94. Additionally, it exhibited desirable characteristics, such as a particle size of 171.2 11.4 nm, a PDI value of 0.317 0.02, and a high drug content of 100.04 0.65%. In conclusion, the presented methodology appeared to be perfect for the optimization of the aripiprazole nanosuspension formula to ensure suitability for nose-to-brain drug delivery.
Top-100
Citing journals
500
1000
1500
2000
2500
|
|
Computer Methods in Biomechanics and Biomedical Engineering
2168 citations, 5.06%
|
|
Journal of Biomechanics
2011 citations, 4.69%
|
|
Journal of Biomechanical Engineering
933 citations, 2.18%
|
|
Journal of the Mechanical Behavior of Biomedical Materials
833 citations, 1.94%
|
|
Biomechanics and Modeling in Mechanobiology
765 citations, 1.79%
|
|
Annals of Biomedical Engineering
658 citations, 1.54%
|
|
Medical Engineering and Physics
643 citations, 1.5%
|
|
Frontiers in Bioengineering and Biotechnology
626 citations, 1.46%
|
|
PLoS ONE
598 citations, 1.4%
|
|
Scientific Reports
575 citations, 1.34%
|
|
International Journal for Numerical Methods in Biomedical Engineering
543 citations, 1.27%
|
|
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine
444 citations, 1.04%
|
|
Clinical Biomechanics
444 citations, 1.04%
|
|
Computer Methods and Programs in Biomedicine
392 citations, 0.92%
|
|
Computers in Biology and Medicine
377 citations, 0.88%
|
|
Applied Sciences (Switzerland)
373 citations, 0.87%
|
|
Medical and Biological Engineering and Computing
352 citations, 0.82%
|
|
Gait and Posture
320 citations, 0.75%
|
|
Sensors
320 citations, 0.75%
|
|
Journal of Orthopaedic Research
270 citations, 0.63%
|
|
Journal of Mechanics in Medicine and Biology
252 citations, 0.59%
|
|
Bone
239 citations, 0.56%
|
|
Bioengineering
229 citations, 0.53%
|
|
Frontiers in Physiology
199 citations, 0.46%
|
|
IEEE Transactions on Biomedical Engineering
187 citations, 0.44%
|
|
Lecture Notes in Computer Science
184 citations, 0.43%
|
|
Computer Methods in Applied Mechanics and Engineering
179 citations, 0.42%
|
|
Materials
179 citations, 0.42%
|
|
Acta Biomaterialia
155 citations, 0.36%
|
|
Physics of Fluids
154 citations, 0.36%
|
|
BioMedical Engineering Online
142 citations, 0.33%
|
|
Cardiovascular Engineering and Technology
136 citations, 0.32%
|
|
Multibody System Dynamics
132 citations, 0.31%
|
|
Journal of the Royal Society Interface
130 citations, 0.3%
|
|
BMC Musculoskeletal Disorders
118 citations, 0.28%
|
|
Computer Methods in Biomechanics and Biomedical Engineering: Imaging and Visualization
113 citations, 0.26%
|
|
Sports Biomechanics
110 citations, 0.26%
|
|
IEEE Access
109 citations, 0.25%
|
|
Journal of Orthopaedic Surgery and Research
108 citations, 0.25%
|
|
IEEE Transactions on Neural Systems and Rehabilitation Engineering
102 citations, 0.24%
|
|
Heliyon
95 citations, 0.22%
|
|
Lecture Notes in Computational Vision and Biomechanics
91 citations, 0.21%
|
|
Applied Bionics and Biomechanics
90 citations, 0.21%
|
|
Lecture Notes in Mechanical Engineering
90 citations, 0.21%
|
|
Journal of Applied Biomechanics
88 citations, 0.21%
|
|
BioMed Research International
85 citations, 0.2%
|
|
European Spine Journal
85 citations, 0.2%
|
|
Journal of Bone and Mineral Research
84 citations, 0.2%
|
|
Biomedical Signal Processing and Control
82 citations, 0.19%
|
|
International journal of computer assisted radiology and surgery
82 citations, 0.19%
|
|
Journal of Clinical Medicine
81 citations, 0.19%
|
|
Archives of Computational Methods in Engineering
79 citations, 0.18%
|
|
Journal of Theoretical Biology
79 citations, 0.18%
|
|
International Journal of Environmental Research and Public Health
78 citations, 0.18%
|
|
Knee Surgery, Sports Traumatology, Arthroscopy
76 citations, 0.18%
|
|
Computational Mechanics
75 citations, 0.18%
|
|
Journal of Electromyography and Kinesiology
73 citations, 0.17%
|
|
Journal of Sports Sciences
73 citations, 0.17%
|
|
Medical Image Analysis
67 citations, 0.16%
|
|
Computational and Mathematical Methods in Medicine
67 citations, 0.16%
|
|
Applied Ergonomics
66 citations, 0.15%
|
|
Knee
66 citations, 0.15%
|
|
Medical Physics
65 citations, 0.15%
|
|
Proceedings of the Institution of Mechanical Engineers, Part P: Journal of Sports Engineering and Technology
65 citations, 0.15%
|
|
World Neurosurgery
64 citations, 0.15%
|
|
PeerJ
64 citations, 0.15%
|
|
Journal of the Mechanics and Physics of Solids
64 citations, 0.15%
|
|
Journal of the Brazilian Society of Mechanical Sciences and Engineering
64 citations, 0.15%
|
|
Injury
63 citations, 0.15%
|
|
Journal of Medical and Biological Engineering
62 citations, 0.14%
|
|
Advances in Intelligent Systems and Computing
62 citations, 0.14%
|
|
Studies in Mechanobiology, Tissue Engineering and Biomaterials
61 citations, 0.14%
|
|
Journal of Shoulder and Elbow Surgery
60 citations, 0.14%
|
|
PLoS Computational Biology
60 citations, 0.14%
|
|
Biomedical Physics and Engineering Express
59 citations, 0.14%
|
|
IEEE Sensors Journal
58 citations, 0.14%
|
|
Acta Mechanica Sinica/Lixue Xuebao
58 citations, 0.14%
|
|
Traffic Injury Prevention
57 citations, 0.13%
|
|
Ergonomics
57 citations, 0.13%
|
|
Journal of NeuroEngineering and Rehabilitation
56 citations, 0.13%
|
|
Spine
53 citations, 0.12%
|
|
Frontiers in Cardiovascular Medicine
53 citations, 0.12%
|
|
Journal of Computational Physics
53 citations, 0.12%
|
|
SAE Technical Papers
53 citations, 0.12%
|
|
Frontiers in Sports and Active Living
53 citations, 0.12%
|
|
Mathematics
52 citations, 0.12%
|
|
International Journal of Mechanical Sciences
52 citations, 0.12%
|
|
Orthopaedic surgery
52 citations, 0.12%
|
|
Journal of Strength and Conditioning Research
51 citations, 0.12%
|
|
Journal of Anatomy
49 citations, 0.11%
|
|
Current Osteoporosis Reports
49 citations, 0.11%
|
|
Journal of Prosthetic Dentistry
47 citations, 0.11%
|
|
Journal of Physics: Conference Series
46 citations, 0.11%
|
|
Sports Engineering
46 citations, 0.11%
|
|
Osteoporosis International
46 citations, 0.11%
|
|
Human Movement Science
46 citations, 0.11%
|
|
Physics in Medicine and Biology
45 citations, 0.11%
|
|
Artificial Organs
45 citations, 0.11%
|
|
Materials and Design
45 citations, 0.11%
|
|
Orthopaedics and Traumatology: Surgery and Research
45 citations, 0.11%
|
|
Show all (70 more) | |
500
1000
1500
2000
2500
|
Citing publishers
2000
4000
6000
8000
10000
12000
|
|
Elsevier
11624 citations, 27.13%
|
|
Springer Nature
7536 citations, 17.59%
|
|
Taylor & Francis
3448 citations, 8.05%
|
|
Wiley
2636 citations, 6.15%
|
|
MDPI
2369 citations, 5.53%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1769 citations, 4.13%
|
|
Frontiers Media S.A.
1354 citations, 3.16%
|
|
SAGE
1142 citations, 2.67%
|
|
ASME International
1129 citations, 2.64%
|
|
Public Library of Science (PLoS)
685 citations, 1.6%
|
|
Ovid Technologies (Wolters Kluwer Health)
519 citations, 1.21%
|
|
Hindawi Limited
495 citations, 1.16%
|
|
World Scientific
430 citations, 1%
|
|
IOP Publishing
401 citations, 0.94%
|
|
Cold Spring Harbor Laboratory
386 citations, 0.9%
|
|
The Royal Society
297 citations, 0.69%
|
|
AIP Publishing
289 citations, 0.67%
|
|
Oxford University Press
137 citations, 0.32%
|
|
IOS Press
131 citations, 0.31%
|
|
American Physiological Society
121 citations, 0.28%
|
|
Human Kinetics
121 citations, 0.28%
|
|
American Chemical Society (ACS)
114 citations, 0.27%
|
|
Georg Thieme Verlag KG
113 citations, 0.26%
|
|
Walter de Gruyter
110 citations, 0.26%
|
|
Royal Society of Chemistry (RSC)
104 citations, 0.24%
|
|
Mary Ann Liebert
102 citations, 0.24%
|
|
Cambridge University Press
98 citations, 0.23%
|
|
EDP Sciences
82 citations, 0.19%
|
|
Trans Tech Publications
80 citations, 0.19%
|
|
PeerJ
78 citations, 0.18%
|
|
American Institute of Mathematical Sciences (AIMS)
72 citations, 0.17%
|
|
BMJ
71 citations, 0.17%
|
|
SAE International
71 citations, 0.17%
|
|
The Company of Biologists
68 citations, 0.16%
|
|
Emerald
62 citations, 0.14%
|
|
Bentham Science Publishers Ltd.
62 citations, 0.14%
|
|
Begell House
61 citations, 0.14%
|
|
Society for Industrial and Applied Mathematics (SIAM)
59 citations, 0.14%
|
|
Association for Computing Machinery (ACM)
56 citations, 0.13%
|
|
Annual Reviews
54 citations, 0.13%
|
|
British Editorial Society of Bone and Joint Surgery
53 citations, 0.12%
|
|
AME Publishing Company
53 citations, 0.12%
|
|
SPIE-Intl Soc Optical Eng
52 citations, 0.12%
|
|
Pleiades Publishing
50 citations, 0.12%
|
|
Korean Society of Mechanical Engineers
47 citations, 0.11%
|
|
ifmbe proceedings
46 citations, 0.11%
|
|
IGI Global
44 citations, 0.1%
|
|
Journal of Neurosurgery Publishing Group (JNSPG)
42 citations, 0.1%
|
|
American Physical Society (APS)
42 citations, 0.1%
|
|
Tissue Viability Society
42 citations, 0.1%
|
|
Research Square Platform LLC
42 citations, 0.1%
|
|
Institution of Engineering and Technology (IET)
36 citations, 0.08%
|
|
Acoustical Society of America (ASA)
36 citations, 0.08%
|
|
The Korean Society of Precision Engineering
36 citations, 0.08%
|
|
Biophysical Society
32 citations, 0.07%
|
|
American Association for the Advancement of Science (AAAS)
29 citations, 0.07%
|
|
JMIR Publications
29 citations, 0.07%
|
|
European Society for Artificial Organs (ESAO)
28 citations, 0.07%
|
|
Scientific Research Publishing
27 citations, 0.06%
|
|
S. Karger AG
25 citations, 0.06%
|
|
SLACK
25 citations, 0.06%
|
|
Mathematical Sciences Publishers
24 citations, 0.06%
|
|
American Society of Civil Engineers (ASCE)
24 citations, 0.06%
|
|
Proceedings of the National Academy of Sciences (PNAS)
23 citations, 0.05%
|
|
Optica Publishing Group
23 citations, 0.05%
|
|
Tech Science Press
23 citations, 0.05%
|
|
Japan Society of Mechanical Engineers
22 citations, 0.05%
|
|
Association for Research in Vision and Ophthalmology (ARVO)
22 citations, 0.05%
|
|
IntechOpen
21 citations, 0.05%
|
|
Allen Press
19 citations, 0.04%
|
|
Mark Allen Group
19 citations, 0.04%
|
|
Alexandria University
18 citations, 0.04%
|
|
Spandidos Publications
17 citations, 0.04%
|
|
The Endocrine Society
17 citations, 0.04%
|
|
XMLink
17 citations, 0.04%
|
|
American Speech Language Hearing Association
16 citations, 0.04%
|
|
14 citations, 0.03%
|
|
American Veterinary Medical Association
13 citations, 0.03%
|
|
eLife Sciences Publications
13 citations, 0.03%
|
|
SciELO
13 citations, 0.03%
|
|
ASTM International
13 citations, 0.03%
|
|
Baishideng Publishing Group
13 citations, 0.03%
|
|
Hans Publishers
13 citations, 0.03%
|
|
British Institute of Radiology
12 citations, 0.03%
|
|
Media Sphere Publishing House
12 citations, 0.03%
|
|
King Saud University
11 citations, 0.03%
|
|
11 citations, 0.03%
|
|
American Institute of Aeronautics and Astronautics (AIAA)
11 citations, 0.03%
|
|
The Korean Academy of prosthodontics
11 citations, 0.03%
|
|
11 citations, 0.03%
|
|
Japan Prosthodontic Society
11 citations, 0.03%
|
|
PAGEPress Publications
11 citations, 0.03%
|
|
European Hip Society
11 citations, 0.03%
|
|
University of Wales Institute, Cardiff
10 citations, 0.02%
|
|
American Society of Neuoradiology
10 citations, 0.02%
|
|
Radiological Society of North America (RSNA)
10 citations, 0.02%
|
|
Portico
10 citations, 0.02%
|
|
Jaypee Brothers Medical Publishing
10 citations, 0.02%
|
|
Arizona State University
9 citations, 0.02%
|
|
Federation of American Societies for Experimental Biology (FASEB)
9 citations, 0.02%
|
|
Show all (70 more) | |
2000
4000
6000
8000
10000
12000
|
Publishing organizations
10
20
30
40
50
60
70
80
|
|
Aix-Marseille University
80 publications, 1.81%
|
|
Katholieke Universiteit Leuven
56 publications, 1.27%
|
|
Sorbonne University
50 publications, 1.13%
|
|
Beihang University
49 publications, 1.11%
|
|
École Polytechnique Fédérale de Lausanne
47 publications, 1.06%
|
|
Grenoble Alpes University
44 publications, 1%
|
|
Polytechnic University of Milan
42 publications, 0.95%
|
|
Université de Lille
39 publications, 0.88%
|
|
Paris Cité University
38 publications, 0.86%
|
|
Université Catholique de Louvain
37 publications, 0.84%
|
|
Université Bourgogne Franche-Comté
37 publications, 0.84%
|
|
Stanford University
35 publications, 0.79%
|
|
Ghent University
34 publications, 0.77%
|
|
ETH Zurich
34 publications, 0.77%
|
|
Polytechnique Montréal
33 publications, 0.75%
|
|
University of Bordeaux
32 publications, 0.72%
|
|
Imperial College London
32 publications, 0.72%
|
|
University of Porto
32 publications, 0.72%
|
|
Université Paris-Saclay
32 publications, 0.72%
|
|
Sichuan University
30 publications, 0.68%
|
|
University of Waterloo
30 publications, 0.68%
|
|
Universite Libre de Bruxelles
29 publications, 0.66%
|
|
Sorbonne Paris Nord University
29 publications, 0.66%
|
|
University of Calgary
29 publications, 0.66%
|
|
University of Lorraine
28 publications, 0.63%
|
|
Eindhoven University of Technology
25 publications, 0.57%
|
|
North Carolina State University
24 publications, 0.54%
|
|
University of Zaragoza
24 publications, 0.54%
|
|
University of Lisbon
23 publications, 0.52%
|
|
University of Auckland
23 publications, 0.52%
|
|
Université Paris-Est Créteil
23 publications, 0.52%
|
|
National University of Singapore
22 publications, 0.5%
|
|
University of Southampton
22 publications, 0.5%
|
|
Harvard University
22 publications, 0.5%
|
|
Cardiff University
22 publications, 0.5%
|
|
University of Ottawa
22 publications, 0.5%
|
|
École de Technologie Supérieure
21 publications, 0.48%
|
|
Shanghai Jiao Tong University
20 publications, 0.45%
|
|
University of Liège
20 publications, 0.45%
|
|
Lausanne University Hospital
19 publications, 0.43%
|
|
University of Sydney
19 publications, 0.43%
|
|
University of Melbourne
19 publications, 0.43%
|
|
University of Michigan
19 publications, 0.43%
|
|
University of Alberta
18 publications, 0.41%
|
|
Université Clermont Auvergne
18 publications, 0.41%
|
|
Pennsylvania State University
17 publications, 0.39%
|
|
University College Dublin
17 publications, 0.39%
|
|
Tel Aviv University
16 publications, 0.36%
|
|
University of Strasbourg
16 publications, 0.36%
|
|
University of Nantes
16 publications, 0.36%
|
|
University of New South Wales
16 publications, 0.36%
|
|
University of Texas at Austin
16 publications, 0.36%
|
|
Cleveland Clinic
16 publications, 0.36%
|
|
Amirkabir University of Technology
15 publications, 0.34%
|
|
University of Pennsylvania
15 publications, 0.34%
|
|
Western University
15 publications, 0.34%
|
|
CentraleSupélec
15 publications, 0.34%
|
|
Peking University
14 publications, 0.32%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
14 publications, 0.32%
|
|
Johns Hopkins University
14 publications, 0.32%
|
|
Virginia Tech
14 publications, 0.32%
|
|
Mayo Clinic
14 publications, 0.32%
|
|
Fudan University
13 publications, 0.29%
|
|
Capital Medical University
13 publications, 0.29%
|
|
Charles University
13 publications, 0.29%
|
|
Trinity College Dublin
13 publications, 0.29%
|
|
University of Erlangen–Nuremberg
13 publications, 0.29%
|
|
Zhejiang University
12 publications, 0.27%
|
|
Tongji University
12 publications, 0.27%
|
|
École normale supérieure Paris-Saclay
12 publications, 0.27%
|
|
University of Padua
12 publications, 0.27%
|
|
Queensland University of Technology
12 publications, 0.27%
|
|
University of Western Australia
12 publications, 0.27%
|
|
University of Sheffield
12 publications, 0.27%
|
|
Universidade Estadual Paulista
12 publications, 0.27%
|
|
Wake Forest University
12 publications, 0.27%
|
|
University of Tehran
11 publications, 0.25%
|
|
Islamic Azad University, Science and Research Branch
11 publications, 0.25%
|
|
University of Oxford
11 publications, 0.25%
|
|
University of Shanghai for Science and Technology
11 publications, 0.25%
|
|
Carnegie Mellon University
11 publications, 0.25%
|
|
Royal Melbourne Institute of Technology
11 publications, 0.25%
|
|
University of British Columbia
11 publications, 0.25%
|
|
RWTH Aachen University
11 publications, 0.25%
|
|
Ulm University
11 publications, 0.25%
|
|
University of Stuttgart
11 publications, 0.25%
|
|
Universidade Estadual de Campinas
11 publications, 0.25%
|
|
University of Denver
11 publications, 0.25%
|
|
Texas A&M University
11 publications, 0.25%
|
|
Vellore Institute of Technology University
10 publications, 0.23%
|
|
University of Twente
10 publications, 0.23%
|
|
Beijing University of Technology
10 publications, 0.23%
|
|
University of Bern
10 publications, 0.23%
|
|
Nanyang Technological University
10 publications, 0.23%
|
|
Southern Medical University
10 publications, 0.23%
|
|
National Yang Ming Chiao Tung University
10 publications, 0.23%
|
|
Rizzoli Orthopaedic Institute
10 publications, 0.23%
|
|
University of Washington
10 publications, 0.23%
|
|
Vienna University of Technology
10 publications, 0.23%
|
|
Rensselaer Polytechnic Institute
10 publications, 0.23%
|
|
Show all (70 more) | |
10
20
30
40
50
60
70
80
|
Publishing organizations in 5 years
5
10
15
20
25
30
|
|
Beihang University
30 publications, 2.6%
|
|
Sichuan University
18 publications, 1.56%
|
|
Sorbonne Paris Nord University
18 publications, 1.56%
|
|
Shanghai Jiao Tong University
12 publications, 1.04%
|
|
Aix-Marseille University
11 publications, 0.95%
|
|
Zhejiang University
10 publications, 0.87%
|
|
Peking University
10 publications, 0.87%
|
|
University of Lorraine
10 publications, 0.87%
|
|
Harvard University
10 publications, 0.87%
|
|
Vellore Institute of Technology University
9 publications, 0.78%
|
|
Fudan University
9 publications, 0.78%
|
|
Tianjin University of Technology
9 publications, 0.78%
|
|
University of Shanghai for Science and Technology
9 publications, 0.78%
|
|
Sorbonne University
9 publications, 0.78%
|
|
Amirkabir University of Technology
8 publications, 0.69%
|
|
Katholieke Universiteit Leuven
8 publications, 0.69%
|
|
Shandong University
8 publications, 0.69%
|
|
University of Waterloo
8 publications, 0.69%
|
|
University of Swat
7 publications, 0.61%
|
|
Tongji University
7 publications, 0.61%
|
|
Universitair Ziekenhuis Leuven
7 publications, 0.61%
|
|
Grenoble Alpes University
7 publications, 0.61%
|
|
Polytechnic University of Milan
7 publications, 0.61%
|
|
Soochow University (Suzhou)
7 publications, 0.61%
|
|
King Mongkut's University of Technology Thonburi
7 publications, 0.61%
|
|
Paris Cité University
7 publications, 0.61%
|
|
University of Pennsylvania
7 publications, 0.61%
|
|
University of Ottawa
7 publications, 0.61%
|
|
Polytechnique Montréal
7 publications, 0.61%
|
|
University of Tehran
6 publications, 0.52%
|
|
Indian Institute of Technology Madras
6 publications, 0.52%
|
|
University of Kashmir
6 publications, 0.52%
|
|
Islamic Azad University, Science and Research Branch
6 publications, 0.52%
|
|
Xi'an Jiaotong University
6 publications, 0.52%
|
|
University of Strasbourg
6 publications, 0.52%
|
|
American University of Beirut
6 publications, 0.52%
|
|
Imperial College London
6 publications, 0.52%
|
|
Tianjin University
6 publications, 0.52%
|
|
Lebanese American University
6 publications, 0.52%
|
|
Shanxi Medical University
6 publications, 0.52%
|
|
Shanghai University
6 publications, 0.52%
|
|
Ningbo University
6 publications, 0.52%
|
|
Virginia Tech
6 publications, 0.52%
|
|
University of Porto
6 publications, 0.52%
|
|
University of Zaragoza
6 publications, 0.52%
|
|
University College Dublin
6 publications, 0.52%
|
|
Firat University
5 publications, 0.43%
|
|
Indian Institute of Technology (Banaras Hindu University) Varanasi
5 publications, 0.43%
|
|
Huazhong University of Science and Technology
5 publications, 0.43%
|
|
South China University of Technology
5 publications, 0.43%
|
|
Sun Yat-sen University
5 publications, 0.43%
|
|
Taiyuan University of Technology
5 publications, 0.43%
|
|
Southern Medical University
5 publications, 0.43%
|
|
National Yunlin University of Science and Technology
5 publications, 0.43%
|
|
Pennsylvania State University
5 publications, 0.43%
|
|
University of Auckland
5 publications, 0.43%
|
|
Stanford University
5 publications, 0.43%
|
|
University of Erlangen–Nuremberg
5 publications, 0.43%
|
|
People's Liberation Army General Hospital and Medical School (301 Hospital)
5 publications, 0.43%
|
|
Cardiff University
5 publications, 0.43%
|
|
Western University
5 publications, 0.43%
|
|
University of Alberta
5 publications, 0.43%
|
|
Wake Forest University
5 publications, 0.43%
|
|
Cleveland Clinic
5 publications, 0.43%
|
|
University of Denver
5 publications, 0.43%
|
|
Université de Lille
5 publications, 0.43%
|
|
King Khalid University
4 publications, 0.35%
|
|
Abdul Wali Khan University
4 publications, 0.35%
|
|
University of Malakand
4 publications, 0.35%
|
|
Banaras Hindu University
4 publications, 0.35%
|
|
Anna University
4 publications, 0.35%
|
|
Erciyes University
4 publications, 0.35%
|
|
Semnan University
4 publications, 0.35%
|
|
University of Isfahan
4 publications, 0.35%
|
|
Koneru Lakshmaiah Education Foundation
4 publications, 0.35%
|
|
SRM Institute of Science and Technology
4 publications, 0.35%
|
|
Indian Institute of Information Technology, Design and Manufacturing, Jabalpur
4 publications, 0.35%
|
|
Dalian University of Technology
4 publications, 0.35%
|
|
University of Lisbon
4 publications, 0.35%
|
|
Nanjing University of Aeronautics and Astronautics
4 publications, 0.35%
|
|
Nanjing University of Science and Technology
4 publications, 0.35%
|
|
Southeast University
4 publications, 0.35%
|
|
Chongqing Medical University
4 publications, 0.35%
|
|
Northeastern University
4 publications, 0.35%
|
|
Capital Medical University
4 publications, 0.35%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
4 publications, 0.35%
|
|
University College London
4 publications, 0.35%
|
|
Tianjin University of Science and Technology
4 publications, 0.35%
|
|
Inner Mongolia University of Technology
4 publications, 0.35%
|
|
University of Melbourne
4 publications, 0.35%
|
|
Royal Melbourne Institute of Technology
4 publications, 0.35%
|
|
North Carolina State University
4 publications, 0.35%
|
|
Budapest University of Technology and Economics
4 publications, 0.35%
|
|
University of Michigan
4 publications, 0.35%
|
|
Marquette University
4 publications, 0.35%
|
|
Xinjiang University
4 publications, 0.35%
|
|
Universidade Estadual Paulista
4 publications, 0.35%
|
|
ITMO University
3 publications, 0.26%
|
|
Southwest State University
3 publications, 0.26%
|
|
King Saud University
3 publications, 0.26%
|
|
Show all (70 more) | |
5
10
15
20
25
30
|
Publishing countries
200
400
600
800
1000
1200
1400
1600
|
|
France
|
France, 1426, 32.3%
France
1426 publications, 32.3%
|
USA
|
USA, 631, 14.29%
USA
631 publications, 14.29%
|
China
|
China, 485, 10.99%
China
485 publications, 10.99%
|
Canada
|
Canada, 290, 6.57%
Canada
290 publications, 6.57%
|
United Kingdom
|
United Kingdom, 225, 5.1%
United Kingdom
225 publications, 5.1%
|
Belgium
|
Belgium, 187, 4.24%
Belgium
187 publications, 4.24%
|
India
|
India, 173, 3.92%
India
173 publications, 3.92%
|
Germany
|
Germany, 159, 3.6%
Germany
159 publications, 3.6%
|
Italy
|
Italy, 152, 3.44%
Italy
152 publications, 3.44%
|
Switzerland
|
Switzerland, 126, 2.85%
Switzerland
126 publications, 2.85%
|
Australia
|
Australia, 124, 2.81%
Australia
124 publications, 2.81%
|
Portugal
|
Portugal, 87, 1.97%
Portugal
87 publications, 1.97%
|
Iran
|
Iran, 84, 1.9%
Iran
84 publications, 1.9%
|
Spain
|
Spain, 84, 1.9%
Spain
84 publications, 1.9%
|
Japan
|
Japan, 81, 1.83%
Japan
81 publications, 1.83%
|
Brazil
|
Brazil, 63, 1.43%
Brazil
63 publications, 1.43%
|
Turkey
|
Turkey, 61, 1.38%
Turkey
61 publications, 1.38%
|
Netherlands
|
Netherlands, 57, 1.29%
Netherlands
57 publications, 1.29%
|
Czech Republic
|
Czech Republic, 51, 1.16%
Czech Republic
51 publications, 1.16%
|
Republic of Korea
|
Republic of Korea, 46, 1.04%
Republic of Korea
46 publications, 1.04%
|
Ireland
|
Ireland, 42, 0.95%
Ireland
42 publications, 0.95%
|
Singapore
|
Singapore, 40, 0.91%
Singapore
40 publications, 0.91%
|
Pakistan
|
Pakistan, 35, 0.79%
Pakistan
35 publications, 0.79%
|
New Zealand
|
New Zealand, 34, 0.77%
New Zealand
34 publications, 0.77%
|
Sweden
|
Sweden, 34, 0.77%
Sweden
34 publications, 0.77%
|
Tunisia
|
Tunisia, 33, 0.75%
Tunisia
33 publications, 0.75%
|
Algeria
|
Algeria, 31, 0.7%
Algeria
31 publications, 0.7%
|
Greece
|
Greece, 30, 0.68%
Greece
30 publications, 0.68%
|
Poland
|
Poland, 29, 0.66%
Poland
29 publications, 0.66%
|
Austria
|
Austria, 28, 0.63%
Austria
28 publications, 0.63%
|
Romania
|
Romania, 26, 0.59%
Romania
26 publications, 0.59%
|
Israel
|
Israel, 23, 0.52%
Israel
23 publications, 0.52%
|
Malaysia
|
Malaysia, 22, 0.5%
Malaysia
22 publications, 0.5%
|
Norway
|
Norway, 22, 0.5%
Norway
22 publications, 0.5%
|
Saudi Arabia
|
Saudi Arabia, 20, 0.45%
Saudi Arabia
20 publications, 0.45%
|
Russia
|
Russia, 19, 0.43%
Russia
19 publications, 0.43%
|
Colombia
|
Colombia, 19, 0.43%
Colombia
19 publications, 0.43%
|
Denmark
|
Denmark, 18, 0.41%
Denmark
18 publications, 0.41%
|
Lebanon
|
Lebanon, 16, 0.36%
Lebanon
16 publications, 0.36%
|
South Africa
|
South Africa, 14, 0.32%
South Africa
14 publications, 0.32%
|
Mexico
|
Mexico, 13, 0.29%
Mexico
13 publications, 0.29%
|
Thailand
|
Thailand, 13, 0.29%
Thailand
13 publications, 0.29%
|
Chile
|
Chile, 13, 0.29%
Chile
13 publications, 0.29%
|
Egypt
|
Egypt, 12, 0.27%
Egypt
12 publications, 0.27%
|
Luxembourg
|
Luxembourg, 12, 0.27%
Luxembourg
12 publications, 0.27%
|
Slovenia
|
Slovenia, 12, 0.27%
Slovenia
12 publications, 0.27%
|
Finland
|
Finland, 12, 0.27%
Finland
12 publications, 0.27%
|
Hungary
|
Hungary, 11, 0.25%
Hungary
11 publications, 0.25%
|
Serbia
|
Serbia, 11, 0.25%
Serbia
11 publications, 0.25%
|
Argentina
|
Argentina, 10, 0.23%
Argentina
10 publications, 0.23%
|
Jordan
|
Jordan, 9, 0.2%
Jordan
9 publications, 0.2%
|
Iraq
|
Iraq, 9, 0.2%
Iraq
9 publications, 0.2%
|
UAE
|
UAE, 8, 0.18%
UAE
8 publications, 0.18%
|
Morocco
|
Morocco, 7, 0.16%
Morocco
7 publications, 0.16%
|
Ukraine
|
Ukraine, 5, 0.11%
Ukraine
5 publications, 0.11%
|
Bangladesh
|
Bangladesh, 5, 0.11%
Bangladesh
5 publications, 0.11%
|
Bulgaria
|
Bulgaria, 5, 0.11%
Bulgaria
5 publications, 0.11%
|
Indonesia
|
Indonesia, 5, 0.11%
Indonesia
5 publications, 0.11%
|
Iceland
|
Iceland, 5, 0.11%
Iceland
5 publications, 0.11%
|
Kazakhstan
|
Kazakhstan, 4, 0.09%
Kazakhstan
4 publications, 0.09%
|
Vietnam
|
Vietnam, 4, 0.09%
Vietnam
4 publications, 0.09%
|
Qatar
|
Qatar, 3, 0.07%
Qatar
3 publications, 0.07%
|
Kuwait
|
Kuwait, 3, 0.07%
Kuwait
3 publications, 0.07%
|
Monaco
|
Monaco, 3, 0.07%
Monaco
3 publications, 0.07%
|
Nigeria
|
Nigeria, 3, 0.07%
Nigeria
3 publications, 0.07%
|
Slovakia
|
Slovakia, 3, 0.07%
Slovakia
3 publications, 0.07%
|
Bahrain
|
Bahrain, 2, 0.05%
Bahrain
2 publications, 0.05%
|
Cuba
|
Cuba, 2, 0.05%
Cuba
2 publications, 0.05%
|
Latvia
|
Latvia, 2, 0.05%
Latvia
2 publications, 0.05%
|
Madagascar
|
Madagascar, 2, 0.05%
Madagascar
2 publications, 0.05%
|
Croatia
|
Croatia, 2, 0.05%
Croatia
2 publications, 0.05%
|
Venezuela
|
Venezuela, 1, 0.02%
Venezuela
1 publication, 0.02%
|
Democratic Republic of the Congo
|
Democratic Republic of the Congo, 1, 0.02%
Democratic Republic of the Congo
1 publication, 0.02%
|
Reunion
|
Reunion, 1, 0.02%
Reunion
1 publication, 0.02%
|
North Macedonia
|
North Macedonia, 1, 0.02%
North Macedonia
1 publication, 0.02%
|
Syria
|
Syria, 1, 0.02%
Syria
1 publication, 0.02%
|
Uganda
|
Uganda, 1, 0.02%
Uganda
1 publication, 0.02%
|
Montenegro
|
Montenegro, 1, 0.02%
Montenegro
1 publication, 0.02%
|
Sri Lanka
|
Sri Lanka, 1, 0.02%
Sri Lanka
1 publication, 0.02%
|
Show all (49 more) | |
200
400
600
800
1000
1200
1400
1600
|
Publishing countries in 5 years
50
100
150
200
250
300
350
|
|
China
|
China, 334, 28.92%
China
334 publications, 28.92%
|
France
|
France, 152, 13.16%
France
152 publications, 13.16%
|
India
|
India, 149, 12.9%
India
149 publications, 12.9%
|
USA
|
USA, 144, 12.47%
USA
144 publications, 12.47%
|
Canada
|
Canada, 53, 4.59%
Canada
53 publications, 4.59%
|
Iran
|
Iran, 48, 4.16%
Iran
48 publications, 4.16%
|
United Kingdom
|
United Kingdom, 43, 3.72%
United Kingdom
43 publications, 3.72%
|
Germany
|
Germany, 41, 3.55%
Germany
41 publications, 3.55%
|
Turkey
|
Turkey, 39, 3.38%
Turkey
39 publications, 3.38%
|
Pakistan
|
Pakistan, 31, 2.68%
Pakistan
31 publications, 2.68%
|
Italy
|
Italy, 22, 1.9%
Italy
22 publications, 1.9%
|
Brazil
|
Brazil, 20, 1.73%
Brazil
20 publications, 1.73%
|
Spain
|
Spain, 20, 1.73%
Spain
20 publications, 1.73%
|
Australia
|
Australia, 17, 1.47%
Australia
17 publications, 1.47%
|
Japan
|
Japan, 17, 1.47%
Japan
17 publications, 1.47%
|
Portugal
|
Portugal, 15, 1.3%
Portugal
15 publications, 1.3%
|
Belgium
|
Belgium, 14, 1.21%
Belgium
14 publications, 1.21%
|
Republic of Korea
|
Republic of Korea, 14, 1.21%
Republic of Korea
14 publications, 1.21%
|
Saudi Arabia
|
Saudi Arabia, 14, 1.21%
Saudi Arabia
14 publications, 1.21%
|
Switzerland
|
Switzerland, 14, 1.21%
Switzerland
14 publications, 1.21%
|
Thailand
|
Thailand, 12, 1.04%
Thailand
12 publications, 1.04%
|
Ireland
|
Ireland, 9, 0.78%
Ireland
9 publications, 0.78%
|
Colombia
|
Colombia, 9, 0.78%
Colombia
9 publications, 0.78%
|
Algeria
|
Algeria, 8, 0.69%
Algeria
8 publications, 0.69%
|
Iraq
|
Iraq, 8, 0.69%
Iraq
8 publications, 0.69%
|
Malaysia
|
Malaysia, 8, 0.69%
Malaysia
8 publications, 0.69%
|
Sweden
|
Sweden, 8, 0.69%
Sweden
8 publications, 0.69%
|
Hungary
|
Hungary, 7, 0.61%
Hungary
7 publications, 0.61%
|
Greece
|
Greece, 7, 0.61%
Greece
7 publications, 0.61%
|
Egypt
|
Egypt, 7, 0.61%
Egypt
7 publications, 0.61%
|
Lebanon
|
Lebanon, 7, 0.61%
Lebanon
7 publications, 0.61%
|
Netherlands
|
Netherlands, 7, 0.61%
Netherlands
7 publications, 0.61%
|
Russia
|
Russia, 6, 0.52%
Russia
6 publications, 0.52%
|
Morocco
|
Morocco, 6, 0.52%
Morocco
6 publications, 0.52%
|
Poland
|
Poland, 6, 0.52%
Poland
6 publications, 0.52%
|
Finland
|
Finland, 6, 0.52%
Finland
6 publications, 0.52%
|
Austria
|
Austria, 5, 0.43%
Austria
5 publications, 0.43%
|
Denmark
|
Denmark, 5, 0.43%
Denmark
5 publications, 0.43%
|
Indonesia
|
Indonesia, 5, 0.43%
Indonesia
5 publications, 0.43%
|
Mexico
|
Mexico, 5, 0.43%
Mexico
5 publications, 0.43%
|
New Zealand
|
New Zealand, 5, 0.43%
New Zealand
5 publications, 0.43%
|
UAE
|
UAE, 5, 0.43%
UAE
5 publications, 0.43%
|
Singapore
|
Singapore, 5, 0.43%
Singapore
5 publications, 0.43%
|
Tunisia
|
Tunisia, 5, 0.43%
Tunisia
5 publications, 0.43%
|
Bangladesh
|
Bangladesh, 4, 0.35%
Bangladesh
4 publications, 0.35%
|
Israel
|
Israel, 4, 0.35%
Israel
4 publications, 0.35%
|
Jordan
|
Jordan, 4, 0.35%
Jordan
4 publications, 0.35%
|
Romania
|
Romania, 4, 0.35%
Romania
4 publications, 0.35%
|
Serbia
|
Serbia, 4, 0.35%
Serbia
4 publications, 0.35%
|
Kazakhstan
|
Kazakhstan, 3, 0.26%
Kazakhstan
3 publications, 0.26%
|
Vietnam
|
Vietnam, 3, 0.26%
Vietnam
3 publications, 0.26%
|
Monaco
|
Monaco, 3, 0.26%
Monaco
3 publications, 0.26%
|
Nigeria
|
Nigeria, 3, 0.26%
Nigeria
3 publications, 0.26%
|
Norway
|
Norway, 3, 0.26%
Norway
3 publications, 0.26%
|
Czech Republic
|
Czech Republic, 3, 0.26%
Czech Republic
3 publications, 0.26%
|
Chile
|
Chile, 3, 0.26%
Chile
3 publications, 0.26%
|
South Africa
|
South Africa, 3, 0.26%
South Africa
3 publications, 0.26%
|
Argentina
|
Argentina, 2, 0.17%
Argentina
2 publications, 0.17%
|
Kuwait
|
Kuwait, 2, 0.17%
Kuwait
2 publications, 0.17%
|
Croatia
|
Croatia, 2, 0.17%
Croatia
2 publications, 0.17%
|
Bahrain
|
Bahrain, 1, 0.09%
Bahrain
1 publication, 0.09%
|
Venezuela
|
Venezuela, 1, 0.09%
Venezuela
1 publication, 0.09%
|
Qatar
|
Qatar, 1, 0.09%
Qatar
1 publication, 0.09%
|
Syria
|
Syria, 1, 0.09%
Syria
1 publication, 0.09%
|
Slovakia
|
Slovakia, 1, 0.09%
Slovakia
1 publication, 0.09%
|
Montenegro
|
Montenegro, 1, 0.09%
Montenegro
1 publication, 0.09%
|
Show all (36 more) | |
50
100
150
200
250
300
350
|
1 profile journal article
Telyshev Dmitry

National Research University of Electronic Technology
137 publications,
742 citations
h-index: 13
1 profile journal article
Kuchumov Alex

Perm National Research Polytechnic University
52 publications,
157 citations
h-index: 6
1 profile journal article
Zifeng Yang
60 publications,
749 citations
h-index: 16
1 profile journal article
Fojt Jaroslav
70 publications,
1 288 citations
h-index: 20
1 profile journal article
Staat Manfred
DSc in Engineering, Professor

Aachen University of Applied Sciences
101 publications,
819 citations
h-index: 16
1 profile journal article
Wang Xiaoyu
37 publications,
593 citations
h-index: 14
1 profile journal article
Sharifi Abbas
31 publications,
1 174 citations
h-index: 18
1 profile journal article
CHAMORET Dominique
27 publications,
349 citations
h-index: 10
1 profile journal article
Owen Herbert
30 publications,
667 citations
h-index: 15